Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$143,820,046
-$13,462,579 QoQ
Shares Held
15,414,796
-1.9% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#6
of 639 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Harding Loevner LP holds $143,820,046 across 1 Drug Manufacturers - Specialty & Generic name. HLN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
15,414,796 | $143,820,046 |
All Filings in HLN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,820,046 | 15,414,796 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $157,282,625 | 15,712,550 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $167,984,595 | 16,615,687 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $160,647,326 | 17,909,401 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $233,854,295 | 22,551,041 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $237,410,067 | 23,071,921 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $230,165,302 | 24,126,342 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $263,315,124 | 24,888,008 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $211,576,819 | 25,614,627 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,686,593 | 2,907,726 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $184,123,123 | 22,372,190 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $187,284,956 | 22,483,188 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $111,121,934 | 13,260,374 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $79,006,945 | 9,706,013 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||